Monday, September 03, 2007 8:47:06 PM
In reply to: janetbg2 who wrote msg# 6740 Date:9/3/2007 1:47:25 PM
Post #of 6741
However, personally, I want to see higher prices. I'm hoping you wish for the same...
===============================================
Of course, I too hope NNVC stops dropping, as I've repurchased shares at a price significantly higher than where we are now.
I've already lost more than 1/2 my money.
However, "hope" doesn't work well on Wall Street.
So, although I may be "hoping" the price reverses and goes up, I am somewhat dubious that such an event will occur.
A while ago I'd previously posted that once NNVC broke 0.65 (which I considered to be a strong support level), anything below that would signal a "freefall".
My premonition was correct.
I know from previous experience with penny stocks, that things can, in fact, get worse before they get better.
You think 0.45 is bad?
Ha! I shudder to think where this "could" go, IF we have a major market correction.
If 90% of DOW stocks go down, and 90% of Nasdaq stocks go down, surely, you don't expect NNVC to go up, do you?
I realize these are not pleasant things to think about, but that's the reality of the stock market.
Especially when you're dealing with OTC or penny stocks.
All bets are tenuous, at best.
I'm sorry to say ...
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM